Professor | Yuan Gao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yuan Gao
Contact Information	yuan_gao@fudan.edu.cn
Language ability	English, Chinese
Province	Shanghai

Upload Avatar (500 x 500)

Name

Yuan Gao

Contact Information

yuan_gao@fudan.edu.cn

Language ability

English, Chinese

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	1995-1998: Bachelor's and Master's in Pharmaceutics, Shenyang Pharmaceutical University 2009: PhD in Medicine, Second Military Medical University 2010-2012: Postdoctoral Research, Chinese Academy of Sciences and University of Alberta Published over 30 SCI papers in journals like Nature Biotech, Theranostics, Pharmacol Res, Adv Mater Authored 10 patents Edited 4 monographs Led over 30 new drug development projects
Work Experience	2017-present: Associate Researcher, School of Pharmacy, Fudan University Previous: New Drug Development and Basic Research, Shanghai Pharmaceutical Group and Changhai Hospital, Second Military Medical University
Awards	2005: Shanghai 'New Long March Pioneer'

University/Lab Affiliation and Title

Fudan University

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

1995-1998: Bachelor's and Master's in Pharmaceutics, Shenyang Pharmaceutical University
2009: PhD in Medicine, Second Military Medical University
2010-2012: Postdoctoral Research, Chinese Academy of Sciences and University of Alberta
Published over 30 SCI papers in journals like Nature Biotech, Theranostics, Pharmacol Res, Adv Mater
Authored 10 patents
Edited 4 monographs
Led over 30 new drug development projects

Work Experience

2017-present: Associate Researcher, School of Pharmacy, Fudan University
Previous: New Drug Development and Basic Research, Shanghai Pharmaceutical Group and Changhai Hospital, Second Military Medical University

Awards

2005: Shanghai 'New Long March Pioneer'

Areas of Focus	Precision Oncology Clinical Big Data Mining Translational Medicine and Drug Development
Publications	The global patent landscape of mRNA for diagnosis and therapy, M Lv, J Chen, Y Peng, L Gong, F Han, J Guo, L Tian, Y Gao, 2023 Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to improve intratumor delivery and chemotherapy of albumin-bound paclitaxel nanoparticles, Wu Y, Xie H, Li Y, Bao X, Lu G, Wen J, Gao Y, Li Y, Zhang Z, 2023 Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics, Y Wang, X Liu, L Gong, W Ding, W Hao, Y Peng, J Zhang, W Cai, Y Gao, 2023 Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia, Li J, Gong C, Chen X, Guo H, Tai Z, Ding N, Gao S, Gao Y, 2023 Mechanisms of Enzalutamide Resistance and Therapeutic Strategies to Overcome it, Wang Y, Chen J, Gao Y, Xu C, 2021 Regulatory oversight of cell-based therapy in China: government’s efforts in patient access and therapeutic innovation, Wu W, Wang Y, Tang Z, Gao Y, Huo Y, 2020 Pediatric drug development in China: Reforms and challenges, Wu W, Tang Z, Chen J, Gao Y, 2019 Identification of the Risks in CAR T-Cell Therapy Clinical Trials in China: A Delphi Study, Wu W, Huo Y, Ding X, Gao Y, 2020 SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nano-system against bone metastatic castration-resistant prostate cancer, Chen J, Wu ZJ, Ding WH, Xiao CW, Gao S, Gao Y, Cai W, 2020 Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment, Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, Qiang L, Gao S, Gao Y, 2017

Areas of Focus

Precision Oncology
Clinical Big Data Mining
Translational Medicine and Drug Development

Publications

The global patent landscape of mRNA for diagnosis and therapy, M Lv, J Chen, Y Peng, L Gong, F Han, J Guo, L Tian, Y Gao, 2023
Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to improve intratumor delivery and chemotherapy of albumin-bound paclitaxel nanoparticles, Wu Y, Xie H, Li Y, Bao X, Lu G, Wen J, Gao Y, Li Y, Zhang Z, 2023
Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics, Y Wang, X Liu, L Gong, W Ding, W Hao, Y Peng, J Zhang, W Cai, Y Gao, 2023
Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia, Li J, Gong C, Chen X, Guo H, Tai Z, Ding N, Gao S, Gao Y, 2023
Mechanisms of Enzalutamide Resistance and Therapeutic Strategies to Overcome it, Wang Y, Chen J, Gao Y, Xu C, 2021
Regulatory oversight of cell-based therapy in China: government’s efforts in patient access and therapeutic innovation, Wu W, Wang Y, Tang Z, Gao Y, Huo Y, 2020
Pediatric drug development in China: Reforms and challenges, Wu W, Tang Z, Chen J, Gao Y, 2019
Identification of the Risks in CAR T-Cell Therapy Clinical Trials in China: A Delphi Study, Wu W, Huo Y, Ding X, Gao Y, 2020
SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nano-system against bone metastatic castration-resistant prostate cancer, Chen J, Wu ZJ, Ding WH, Xiao CW, Gao S, Gao Y, Cai W, 2020
Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment, Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, Qiang L, Gao S, Gao Y, 2017

Precision Oncology Cancer Treatment Targeted Therapy Clinical Trials Big Data Data Mining Translational Medicine Drug Development Pharmacology Biomedical Research

Yu Tang - Zhejiang University

Zhenjun Yang - Peking University

Ke-Wu Zeng - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us